X-ray exam of kidney lesion
CPT code 74470 covers an X-ray examination performed to evaluate a specific lesion or abnormality in the kidney. This imaging procedure helps doctors visualize kidney masses, cysts, or other structural abnormalities using contrast material.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Verify that documentation clearly identifies the specific lesion being evaluated and distinguishes this from a complete urogram (74400-74420)
Impact: Prevents downcoding or denial; improper code selection could result in $50-150 payment differential depending on alternative code
Document whether contrast material was administered and specify type and amount in the radiology report
Impact: Essential for medical necessity support; absence of contrast documentation can trigger automatic denials requiring costly appeals
Bill the global code (without modifiers) only when your facility owns the equipment and employs both the technologist and interpreting physician
Impact: Ensures full $24.26 reimbursement; incorrect global billing when only providing one component constitutes overbilling
Ensure the ordering physician's documentation supports medical necessity with specific indication beyond 'rule out kidney disease'
Impact: Vague indications trigger 15-25% denial rates; specific lesion characterization indication improves first-pass acceptance
When billing with modifier 26, verify the technical facility has billed or will bill the TC to avoid payment suspension
Impact: Split billing coordination errors cause 30-60 day payment delays and potential recoupment if both components aren't properly documented
Check for frequency limitations in your payer contracts; Medicare typically allows reasonable and necessary repeat studies but may question multiple studies within 90 days
Impact: Proactive ABN (Advanced Beneficiary Notice) collection when medical necessity may be questioned protects against $24.26 write-off per denied study
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.